IDX Nanosensors by dNANO

London, United Kingdom Biotech, meditech, diagnostics, IVD, rapid test

Short Summary

dNANO is developing a R&D driven, novel, industry beating, Nanosensor technology based, In Vitro Diagnostic Test for the diagnosis of Infectious and Non Infectious Diseases including COVID19, Flu, Malaria,TB, STIs, Cancers and Metabolic Diseases

Highlights

  • Transforming Nanotech based In Vitro Diagnostic Test for multiple diseases
  • Rapid results in 5 mins, Self Use or Point of Care Test, 50x more sensitive
  • Prototype ready by July 2021, First product to market early 2022
  • An excellent highly qualified and experienced team
  • Suitable for the global healthcare market, Government, NGOs, Retail, DTC

Overview

Target
£3,000,000
Minimum
£250,000
Invested
£200,000
Previous Rounds £200,000
Stage Pre-Startup/R&D
Investor Role Silent
Please Note: Investments of this nature carry risks to your capital as well as potential rewards. Please read our Risk Warning and Disclaimer before deciding to invest.

Sign up or log in now

Sign up now to gain full access to pitches and investor profiles

global:publish_msg_immediate




global:publish_msg



Congratulations!


You have passed the test and you may continue your with your investment.